Pharmaceutical companies Moderna and Merck & Co are developing an experimental cancer vaccine that a mid-stage study showed to cut the chance of recurrence or death from melanoma - the most deadly skin cancer - by half after three years of treatment.
Moscow : Russian scientists have developed a vaccine for the treatment of cancer that can increase the patient's lifespan more than two-fold, ITAR-TASS reported Wednesday.The vaccine, developed at the Institute of Clinical Immunology in the
Top News
Latest News
